China’s vaccine candidate for Covid-19 turns out safe in clinical trials
China’s potential Covid-19 vaccine candidate BBIP-CorV, which was under human trial observations, has been proven to be safe with the anticipated antibody immune responses, according to Chinese researchers. From the time period between April 29 to July 30, the vaccine was under the combined early and mid-stage clinical trials. The potential vaccine is being developed…